Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Influential Periods in Longitudinal Clinical Cardiovascular Health Scores

Pahkala Katja; Labarthe Darwin; Aguayo Liliana; Greenland Philip; Webber Larry S; Juonala Markus; Allen Norrina B; Krefman Amy E; Muggeo Vito M R; Bazzano Lydia; Lehtimäki Terho; Raitakari Olli; Kähönen Mika; Liu Lei; Day R Sue; Laitinen Tomi T; Van Horn Linda; Pool Lindsay; Lloyd-Jones Donald M

Influential Periods in Longitudinal Clinical Cardiovascular Health Scores

Pahkala Katja
Labarthe Darwin
Aguayo Liliana
Greenland Philip
Webber Larry S
Juonala Markus
Allen Norrina B
Krefman Amy E
Muggeo Vito M R
Bazzano Lydia
Lehtimäki Terho
Raitakari Olli
Kähönen Mika
Liu Lei
Day R Sue
Laitinen Tomi T
Van Horn Linda
Pool Lindsay
Lloyd-Jones Donald M
Katso/Avaa
Publisher's version (279.5Kb)
Lataukset: 

doi:10.1093/aje/kwab149
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2022012710822
Tiivistelmä

The prevalence of ideal cardiovascular health (CVH) among adults in the United States is low and decreases with age. Our objective was to identify specific age windows when the loss of CVH accelerates, to ascertain preventive opportunities for intervention. Data were pooled from 5 longitudinal cohorts (Project Heartbeat!, Cardiovascular Risk in Young Finns Study, The Bogalusa Heart Study, Coronary Artery Risk Development in Young Adults, Special Turku Coronary Risk Factor Intervention Project) from the United States and Finland from 1973 to 2012. Individuals with clinical CVH factors (i.e., body mass index, blood pressure, cholesterol, blood glucose) measured from ages 8 to 55 years were included. These factors were categorized and summed into a clinical CVH score ranging from 0 (worst) to 8 (best). Adjusted, segmented, linear mixed models were used to estimate the change in CVH over time. Among the 18,343 participants, 9,461 (52%) were female and 12,346 (67%) were White. The baseline mean (standard deviation) clinical CVH score was 6.9 (1.2) at an average age of 17.6 (8.1) years. Two inflection points were estimated: at 16.9 years (95% confidence interval: 16.4, 17.4) and at 37.2 years (95% confidence interval: 32.4, 41.9). Late adolescence and early middle age appear to be influential periods during which the loss of CVH accelerates.

Kokoelmat
  • Rinnakkaistallenteet [19207]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste